EMA Heeds Ombudsman’s Advice On Avoiding Perception Of Bias In Drug Evaluations

Changes Are In Response To An Inquiry By EU Ombudsman

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".